Integrated Diagnostics is trading at 20.00 as of the 25th of December 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 20.0. Integrated Diagnostics has hardly any chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 4th of February 2023 and ending today, the 25th of December 2024. Click here to learn more.
Although Integrated Diagnostics' alpha and beta are two of the key measurements used to evaluate Integrated Diagnostics' performance over the market, the standard measures of volatility play an important role as well.
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Integrated Diagnostics stock to make a market-neutral strategy. Peer analysis of Integrated Diagnostics could also be used in its relative valuation, which is a method of valuing Integrated Diagnostics by comparing valuation metrics with similar companies.